Bernd Bokemeyer

26PUBLICATIONS
73CO-AUTHORS
Epidemiological methodsGene expression (incl. microarray and other genome-wide approaches)Work integrated learning (incl. internships)Immunogenetics (incl. genetic immunology)Cross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 15, 2026
Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in Germany.

|May 25, 2026
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

|Apr 03, 2026
Competence network inflammatory bowel diseases in Germany: 25 years of interdisciplinary and cross-sectoral research and knowledge transfer across all levels of IBD care.

Bernd Bokemeyer, Sandra Plachta-Danielzik, Ulf Helwig

|Oct 29, 2025
Real-World Effectiveness of Golimumab in Ulcerative Colitis: A Pooled Analysis from the Prospective UMBRELLA-IBD Registry in Germany.

Arne Bokemeyer, Thomas Wenske, Sandra Plachta-Danielzik

|Oct 17, 2025
Healthcare resource utilization and cost in pediatric celiac disease: A case-control study using German insurance data.

Sibylle Koletzko, Svitlana Schnaidt, Leonarda Serdani-Neuhaus

|May 13, 2025
Six-Year Observation Data Reveal Reduction in Concomitant Steroid Overuse for Inflammatory Bowel Disease in Germany.

Ann-Sophie Stratil, Benjamin Friedrich, Patrizia Brunner

Pageof 5

Frequent Collaborators

4 joint publications

Niels Teich

4 joint publications

Sandra Plachta-Danielzik

3 joint publications

Svitlana Schnaidt

3 joint publications

Stefan Schreiber